# Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

> **NCT04871711** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 487 (actual)

## Conditions studied

- Chronic Hand Eczema

## Interventions

- **DRUG:** Delgocitinib cream
- **DRUG:** Cream vehicle

## Key facts

- **NCT ID:** NCT04871711
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-10
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04871711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04871711, "Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04871711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*